KLF4 and neoplasm: The fact that KLF4 acts as a tumor suppressor that is downregulated in certain cancers (21) led to the identification of a small molecule inducer of KLF4 — APTO-253 (22) — that has undergone limited studies in both mouse models of and selected human cancers (23, 24).